Stock chart
Ticker: XENE Exchange: NMS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
Sept. 7, 2022 Sept. 2, 2022 S Sale

AULIN SHERRY

Chief Financial Officer

Officer
15,355 -100.0%
39.57
607,597 USD
15,355 -100.0% 39.57 607,597 USD
Sept. 2, 2022 Sept. 1, 2022 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
8,776 -34.3%
38.80
340,509 USD
8,776 -34.3% 38.80 340,509 USD
Sept. 2, 2022 Sept. 1, 2022 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
35,103 -57.9%
38.03
1,334,967 USD
35,103 -57.9% 38.03 1,334,967 USD
Sept. 2, 2022 Aug. 31, 2022 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
21,352 -56.0%
38.57
823,547 USD
21,352 -56.0% 38.57 823,547 USD
Aug. 16, 2022 Aug. 16, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
20,000 -76.9%
38.87
777,400 USD
20,000 -76.9% 38.87 777,400 USD
Aug. 16, 2022 Aug. 16, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
32,058 -55.2%
38.29
1,227,501 USD
32,058 -55.2% 38.29 1,227,501 USD
Aug. 16, 2022 Aug. 15, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
33,942 -36.9%
37.76
1,281,650 USD
33,942 -36.9% 37.76 1,281,650 USD
Aug. 16, 2022 Aug. 12, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
1,000 -1.1%
39.15
39,150 USD
1,000 -1.1% 39.15 39,150 USD
Aug. 16, 2022 Aug. 12, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
47,000 -33.6%
38.60
1,814,200 USD
47,000 -33.6% 38.60 1,814,200 USD
Aug. 16, 2022 Aug. 12, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
43,135 -23.6%
37.91
1,635,248 USD
43,135 -23.6% 37.91 1,635,248 USD
Aug. 16, 2022 Aug. 12, 2022 S Sale

EMPFIELD JAMES R.

EVP, Drug Discovery

Officer
21,875 -68.6%
38.68
846,125 USD
21,875 -68.6% 38.68 846,125 USD
Aug. 16, 2022 Aug. 12, 2022 S Sale

EMPFIELD JAMES R.

EVP, Drug Discovery

Officer
35,868 -52.9%
38.08
1,365,853 USD
35,868 -52.9% 38.08 1,365,853 USD
March 8, 2022 March 8, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,500 -1.3%
30.50
76,250 USD
2,500 -1.3% 30.50 76,250 USD
March 8, 2022 March 8, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,500 -1.3%
30.55
76,375 USD
2,500 -1.3% 30.55 76,375 USD
March 8, 2022 March 8, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,500 -1.3%
30.20
75,500 USD
2,500 -1.3% 30.20 75,500 USD
March 8, 2022 March 8, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,500 -1.3%
30.10
75,250 USD
2,500 -1.3% 30.10 75,250 USD
March 8, 2022 March 8, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,500 -1.3%
3.80
9,500 USD
2,500 -1.3% 3.80 9,500 USD
March 8, 2022 March 8, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,051 -1.0%
30.60
62,761 USD
2,051 -1.0% 30.60 62,761 USD
March 8, 2022 March 7, 2022 S Sale

EMPFIELD JAMES R.

EVP, Drug Discovery

Officer
31,048 -75.6%
30.54
948,206 USD
31,048 -75.6% 30.54 948,206 USD
March 8, 2022 March 7, 2022 S Sale

EMPFIELD JAMES R.

EVP, Drug Discovery

Officer
1,805 -4.2%
30.62
55,269 USD
1,805 -4.2% 30.62 55,269 USD
March 8, 2022 March 7, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,500 -1.2%
30.55
76,375 USD
2,500 -1.2% 30.55 76,375 USD
March 8, 2022 March 7, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
7,500 -3.6%
30.50
228,750 USD
7,500 -3.6% 30.50 228,750 USD
March 8, 2022 March 7, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
2,500 -1.2%
30.52
76,300 USD
2,500 -1.2% 30.52 76,300 USD
March 8, 2022 March 7, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
4,516 -2.1%
30.44
137,467 USD
4,516 -2.1% 30.44 137,467 USD
March 8, 2022 March 7, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
4,516 -2.1%
30.45
137,512 USD
4,516 -2.1% 30.45 137,512 USD
March 8, 2022 March 7, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
4,517 -2.0%
30.49
137,723 USD
4,517 -2.0% 30.49 137,723 USD
March 8, 2022 March 7, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
5,037 -2.2%
30.60
154,132 USD
5,037 -2.2% 30.60 154,132 USD
March 8, 2022 March 4, 2022 S Sale

EMPFIELD JAMES R.

EVP, Drug Discovery

Officer
18,315 -64.7%
30.79
563,919 USD
18,315 -64.7% 30.79 563,919 USD
March 8, 2022 March 4, 2022 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
5,000 -22.5%
30.23
151,150 USD
5,000 -22.5% 30.23 151,150 USD
March 8, 2022 March 4, 2022 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
5,000 -18.4%
31.05
155,250 USD
5,000 -18.4% 31.05 155,250 USD
March 8, 2022 March 4, 2022 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
5,000 -15.5%
30.15
150,750 USD
5,000 -15.5% 30.15 150,750 USD
March 8, 2022 March 4, 2022 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
6,710 -17.2%
30.56
205,058 USD
6,710 -17.2% 30.56 205,058 USD
March 8, 2022 March 4, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
4,793 -2.2%
30.56
146,474 USD
4,793 -2.2% 30.56 146,474 USD
March 8, 2022 March 4, 2022 S Sale

PIMSTONE SIMON N.

Non-Executive Director
4,532 -2.1%
30.66
138,951 USD
4,532 -2.1% 30.66 138,951 USD
Jan. 21, 2022 Jan. 21, 2022 B Purchase

KENNEY CHRISTOPHER JOHN

Chief Medical Officer

Officer
700 +inf%
28.81
20,167 USD
700 +inf% 28.81 20,167 USD
Dec. 7, 2021 Dec. 6, 2021 B Purchase

Von Seggern Christopher

Chief Commercial Officer

Officer
4,000 +inf%
24.40
97,600 USD
4,000 +inf% 24.40 97,600 USD
Nov. 16, 2021 Nov. 15, 2021 S Sale

PIMSTONE SIMON N.

Non-Executive Director
17,557 -7.7%
31.33
550,061 USD
17,557 -7.7% 31.33 550,061 USD
June 1, 2021 May 28, 2021 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
2,912 -8.3%
18.81
54,775 USD
2,912 -8.3% 18.81 54,775 USD
June 1, 2021 May 28, 2021 S Sale

ROBIN SHERRINGTON

EVP, Strategy & Innovation

Officer
3,155 -8.2%
18.81
59,346 USD
3,155 -8.2% 18.81 59,346 USD
June 1, 2021 May 27, 2021 S Sale

HOLLER FRANK A

Non-Executive Director
8,485 -5.6%
18.68
158,500 USD
8,485 -5.6% 18.68 158,500 USD
June 1, 2021 May 27, 2021 S Sale

HOLLER FRANK A

Non-Executive Director
2,579 -1.7%
18.69
48,202 USD
2,579 -1.7% 18.69 48,202 USD
June 2, 2020 June 1, 2020 S Sale

PIMSTONE SIMON N.

CEO

Executive Director
3,000 -1.2%
14.43
43,290 USD
3,000 -1.2% 14.43 43,290 USD
June 2, 2020 May 29, 2020 S Sale

PIMSTONE SIMON N.

CEO

Executive Director
5,000 -1.9%
13.99
69,950 USD
5,000 -1.9% 13.99 69,950 USD
Sept. 24, 2019 Sept. 20, 2019 S Sale

PIMSTONE SIMON N.

CEO

Executive Director
10,395 -3.9%
9.51
98,856 USD
10,395 -3.9% 9.51 98,856 USD
Sept. 20, 2019 Sept. 20, 2019 S Sale

HOLLER FRANK A

5,206 -4.2%
9.39
48,884 USD
5,206 -4.2% 9.39 48,884 USD
Sept. 20, 2019 Sept. 19, 2019 S Sale

HOLLER FRANK A

7,600 -5.8%
9.27
70,452 USD
7,600 -5.8% 9.27 70,452 USD
Sept. 18, 2019 Sept. 18, 2019 S Sale

HOLLER FRANK A

4,368 -3.2%
9.28
40,535 USD
4,368 -3.2% 9.28 40,535 USD
Sept. 18, 2019 Sept. 17, 2019 S Sale

HOLLER FRANK A

5,069 -3.6%
9.32
47,243 USD
5,069 -3.6% 9.32 47,243 USD
Sept. 17, 2019 Sept. 13, 2019 S Sale

AZAB MOHAMMAD

23 -0.0%
9.31
214 USD
23 -0.0% 9.31 214 USD
Nov. 16, 2017 Nov. 15, 2017 B Purchase

AZAB MOHAMMAD

15,000 +51.4%
2.22
33,281 USD
15,000 +51.4% 2.22 33,281 USD
Sept. 25, 2017 Sept. 22, 2017 B Purchase

AZAB MOHAMMAD

8,000 +37.7%
2.95
23,600 USD
8,000 +37.7% 2.95 23,600 USD
Sept. 25, 2017 Sept. 21, 2017 B Purchase

AZAB MOHAMMAD

2,000 +10.4%
2.95
5,900 USD
2,000 +10.4% 2.95 5,900 USD
Aug. 21, 2017 Aug. 18, 2017 B Purchase

WINQUIST RAYMOND

Head, Translational Research

1,000 +inf%
3.00
2,995 USD
1,000 +inf% 3.00 2,995 USD
Aug. 21, 2017 Aug. 18, 2017 B Purchase

AZAB MOHAMMAD

6,312 +48.9%
2.90
18,302 USD
6,312 +48.9% 2.90 18,302 USD
Aug. 21, 2017 Aug. 17, 2017 B Purchase

AZAB MOHAMMAD

23 +0.2%
2.65
61 USD
23 +0.2% 2.65 61 USD
Aug. 17, 2017 Aug. 15, 2017 B Purchase

EMPFIELD JAMES R.

SVP, Drug Discovery

10,000 +inf%
2.48
24,824 USD
10,000 +inf% 2.48 24,824 USD
Aug. 16, 2017 Aug. 15, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
7,429 +0.7%
2.41
17,920 USD
7,429 +0.7% 2.41 17,920 USD
Aug. 16, 2017 Aug. 15, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
11,429 +0.7%
2.41
27,569 USD
11,429 +0.7% 2.41 27,569 USD
Aug. 16, 2017 Aug. 14, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
13,337 +1.3%
2.70
36,058 USD
13,337 +1.3% 2.70 36,058 USD
Aug. 16, 2017 Aug. 14, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
28,007 +1.7%
2.70
75,720 USD
28,007 +1.7% 2.70 75,720 USD
Aug. 15, 2017 Aug. 14, 2017 B Purchase

Svoronos Dawn

50,000 +inf%
2.82
140,770 USD
50,000 +inf% 2.82 140,770 USD
Aug. 14, 2017 Aug. 14, 2017 B Purchase

Hayden Michael R

15,000 +10.3%
2.75
41,247 USD
15,000 +10.3% 2.75 41,247 USD
Aug. 14, 2017 Aug. 11, 2017 B Purchase

GANNON STEVEN

15,000 +inf%
2.82
42,267 USD
15,000 +inf% 2.82 42,267 USD
Aug. 14, 2017 Aug. 10, 2017 B Purchase

MORTIMER IAN

CFO & COO

10,000 +232.6%
2.90
29,000 USD
10,000 +232.6% 2.90 29,000 USD
Aug. 14, 2017 Aug. 10, 2017 B Purchase

MORTIMER IAN

CFO & COO

5,000 +500.0%
2.85
14,225 USD
5,000 +500.0% 2.85 14,225 USD
Aug. 14, 2017 Aug. 10, 2017 B Purchase

SCHELLER RICHARD H

7,000 +inf%
2.85
19,950 USD
7,000 +inf% 2.85 19,950 USD
Aug. 14, 2017 Aug. 10, 2017 B Purchase

PATOU GARY

7,500 +150.0%
2.78
20,836 USD
7,500 +150.0% 2.78 20,836 USD
Aug. 14, 2017 Aug. 10, 2017 B Purchase

PIMSTONE SIMON N.

President & CEO

Executive Director
6,000 +2.8%
2.90
17,400 USD
6,000 +2.8% 2.90 17,400 USD
Aug. 10, 2017 Aug. 8, 2017 B Purchase

PATOU GARY

5,000 +inf%
3.00
15,003 USD
5,000 +inf% 3.00 15,003 USD
June 29, 2017 June 27, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
8,496 +2.9%
4.00
33,984 USD
8,496 +2.9% 4.00 33,984 USD
June 29, 2017 June 27, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
30,170 +2.9%
4.00
120,680 USD
30,170 +2.9% 4.00 120,680 USD
June 29, 2017 June 27, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
46,795 +2.9%
4.00
187,180 USD
46,795 +2.9% 4.00 187,180 USD
June 23, 2017 June 22, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
854 +0.3%
4.00
3,416 USD
854 +0.3% 4.00 3,416 USD
June 23, 2017 June 22, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
2,884 +0.3%
4.00
11,536 USD
2,884 +0.3% 4.00 11,536 USD
June 23, 2017 June 22, 2017 B Purchase

BVF PARTNERS L P/IL

Major owner
4,525 +0.3%
4.00
18,100 USD
4,525 +0.3% 4.00 18,100 USD